- Home
- VTVT vs MAIA Comparison
VTVT vs MAIA Comparison
Compare VTVT & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- MAIA
- Stock Information
- Founded
- VTVT 2015
- MAIA 2018
- Country
- VTVT United States
- MAIA United States
- Employees
- VTVT N/A
- MAIA N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VTVT Health Care
- MAIA Health Care
- Exchange
- VTVT Nasdaq
- MAIA Nasdaq
- Market Cap
- VTVT N/A
- MAIA 46.7M
- IPO Year
- VTVT 2015
- MAIA 2022
- Fundamental
- Price
- VTVT $20.08
- MAIA $1.96
- Analyst Decision
- VTVT Strong Buy
- MAIA
- Analyst Count
- VTVT 2
- MAIA 0
- Target Price
- VTVT $35.50
- MAIA N/A
- AVG Volume (30 Days)
- VTVT 8.5K
- MAIA 319.8K
- Earning Date
- VTVT 05-20-2025
- MAIA 05-20-2025
- Dividend Yield
- VTVT N/A
- MAIA N/A
- EPS Growth
- VTVT N/A
- MAIA N/A
- EPS
- VTVT N/A
- MAIA N/A
- Revenue
- VTVT $1,017,000.00
- MAIA N/A
- Revenue This Year
- VTVT N/A
- MAIA N/A
- Revenue Next Year
- VTVT N/A
- MAIA N/A
- P/E Ratio
- VTVT N/A
- MAIA N/A
- Revenue Growth
- VTVT N/A
- MAIA N/A
- 52 Week Low
- VTVT $12.12
- MAIA $1.40
- 52 Week High
- VTVT $29.01
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- VTVT 50.66
- MAIA 52.24
- Support Level
- VTVT $19.49
- MAIA $1.80
- Resistance Level
- VTVT $22.37
- MAIA $2.18
- Average True Range (ATR)
- VTVT 1.28
- MAIA 0.31
- MACD
- VTVT -0.14
- MAIA -0.01
- Stochastic Oscillator
- VTVT 27.61
- MAIA 35.00
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.